| Literature DB >> 11532559 |
E J Pretell1, H H García, R H Gilman, H Saavedra, M Martinez.
Abstract
A recently described one-day regimen of praziquantel (PZQ) therapy for neurocysticercosis (NCC), three doses of 25 mg/k given at 2 h intervals, was applied in eight patients with viable NCC cysts without any evidence of inflammation. Resolution of lesions in computed tomography (CT) was observed in all five patients with a single cyst, whereas all cysts survived in three patients with multiple brain parasites. One-day praziquantel is a good regimen for patients with a single viable brain cysticercus but is poorly effective for multiple cysts.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11532559 DOI: 10.1016/s0303-8467(01)00137-8
Source DB: PubMed Journal: Clin Neurol Neurosurg ISSN: 0303-8467 Impact factor: 1.876